AWM
TNDM icon

Abound Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Abound Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$96 – 1563
2026
Q1 		$96 Sell
5
-1
-17% -$22 ﹤0.01% 1424
2025
Q4 		$132 Hold
6
– – ﹤0.01% 1327
2025
Q3 		$73 Hold
6
– – ﹤0.01% 1329
2025
Q2 		$112 Hold
6
– – ﹤0.01% 1230
2025
Q1 		$115 Hold
6
– – ﹤0.01% 1201
2024
Q4 		$217 Hold
6
– – ﹤0.01% 1025
2024
Q3 		$255 Sell
6
-1
-14% -$42 ﹤0.01% 1032
2024
Q2 		$283 Sell
7
-3
-30% -$125 ﹤0.01% 1003
2024
Q1 		$355 Hold
10
– – ﹤0.01% 1055
2023
Q4 		$296 Buy
10
+3
+43% +$62 ﹤0.01% 1167
2023
Q3 		$146 Hold
7
– – ﹤0.01% 1133
2023
Q2 		$172 Buy
+7
New +$225 ﹤0.01% 1165

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Abound Wealth Management's TNDM Position: Q2 2026 in Review

Abound Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 5 shares — an estimated $96 sold.

Abound Wealth Management first reported a position in TNDM in Q2 2023 and held it in 12 quarters. The position peaked at $355 in Q1 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Abound Wealth Management reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Abound Wealth Management sold 5 Tandem Diabetes Care shares in Q2 2026, an estimated $96.
  • Abound Wealth Management first reported a position in Tandem Diabetes Care in Q2 2023 and held it in 12 quarters.
  • Abound Wealth Management's Tandem Diabetes Care position peaked at $355 in Q1 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.